NIH obtains formal approval from regulatory body for Phase III clinical trial of Covid-19 vaccine
NIH obtains formal approval from regulatory body for Phase III clinical trial of Covid-19 vaccine
This page is also available in
Article Author: NIH obtains formal approval from regulatory body for Phase III clinical trial of Covid-19 vaccine
Media Source: Dawn (Pakistan)
Date: 18 August 2020
In Pakistan, the National Institute of Health (NIH) announced that it had obtained formal approval for the Phase III clinical trial of a Covid-19 vaccine. NIH said that this will be the first ever phase III clinical trial for any vaccine in Pakistan. The study will be conducted in prestigious medical centres in the country…
In Pakistan, the National Institute of Health (NIH) announced that it had obtained formal approval for the Phase III clinical trial of a Covid-19 vaccine. NIH said that this will be the first ever phase III clinical trial for any vaccine in Pakistan. The study will be conducted in prestigious medical centres in the country, including the Aga Khan University Hospital. This initiative can open the door towards public-private partnership to involve the private sector and will help to enhance indigenous vaccine manufacturing capabilities to achieve self-reliance.